Skip to content
Hydroxyprogesterone caproate
Delalutin (hydroxyprogesterone caproate) is a small molecule pharmaceutical. Hydroxyprogesterone caproate was first approved as Hydroxyprogesterone caproate on 1982-01-01.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Hydroxyprogesterone caproate
Tradename
Company
Number
Date
Products
HYDROXYPROGESTERONE CAPROATEAkornN-018004 DISCN1982-01-01
1 products
HYDROXYPROGESTERONE CAPROATEAllerganN-017439 DISCN1982-01-01
2 products
DELALUTINBristol Myers SquibbN-010347 DISCN1982-01-01
2 products, RLD
DELALUTINBristol Myers SquibbN-016911 DISCN1982-01-01
2 products, RLD
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
hydroxyprogesterone caproateANDA2021-11-15
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
Code
Description
J1726
Injection, hydroxyprogesterone caproate, (makena), 10 mg
J1729
Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameHYDROXYPROGESTERONE CAPROATE
INNhydroxyprogesterone caproate
Description
Hydroxyprogesterone caproate is a corticosteroid hormone.
Classification
Small molecule
Drug classprogestins; steroids (androgens, anabolics); antiandrogens
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CCCCCC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C
Identifiers
PDB—
CAS-ID630-56-8
RxCUI12488
ChEMBL IDCHEMBL1200848
ChEBI ID5812
PubChem CID169870
DrugBankDB06789
UNII ID276F2O42F5 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 544 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
11 adverse events reported
View more details